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Case Report

Hemodynamic Effects of Left-Atrial Venous Arterial
Extra-Corporeal Membrane Oxygenation (LAVA-ECMO)
Gulmohar Singh-Kucukarslan ,* Mohamad Raad,† Waleed Al-Darzi ,† Jennifer Cowger ,† Lizbeth Brice,†
Mir B. Basir ,† William W. O’Neill,‡ Khaldoon Alaswaad,† and Marvin H. Eng §

Case Report

We report a case of a 59-year-old male in post-myocardial
infarction cardiogenic shock undergoing left atrial venous
arterial extracorporeal membrane oxygenation (LAVAECMO) as a bridge to transplantation. The unique feature of
this ECMO configuration is use of a single trans-septal cannula to provide biventricular unloading and use of a single
arterial access. ASAIO Journal 2021; 00;00–00

A 59-year-old man with a history of 3-vessel coronary artery
disease with prior bypass surgery presented with an acute inferior MI complicated by cardiogenic shock and unsuccessful
revascularization. An emergent Impella CP (Abiomed, Danvers,
MA) was inserted; however, the cardiac index remained only
1.2 L/min/m2. Echocardiography revealed an LV ejection fraction of 30% with severe functional mitral regurgitation. The
patient’s hospital course was complicated by incessant ventricular tachycardia, escalating vasopressors and inotropes,
and worsening invasive hemodynamics prompting MCS escalation with LAVA-ECMO. Trans-septal puncture using intracardiac echocardiography guidance and balloon septostomy
facilitated placement of a VFEM024 24Fr cannula (Figure 2 and
Supplemental Video 1 http://links.lww.com/ASAIO/A757).
Anti-Xa were maintained at 0.3–0.7 with unfractionated heparin. LAVA-ECMO decreased the mean pulmonary artery pressure from 38 mm Hg to 10 mm Hg and increased the CI from
1.8 to 5.1 L/min/m2 (Table 1).
Five days after cannulation, multiple attempts to wean
LAVA-ECMO failed. When clamped, the mean pulmonary
artery pressure would increase significantly accompanied
by cardiac index decrease (Table 1). After two failed weans,
the patient was listed for orthotopic heart transplantation and
ultimately received a donor heart 11 days after LAVA-ECMO
insertion.

Key Words: assisted circulation, heart failure, ventricular
assist device, cardiovascular physiology

C

ardiogenic shock (CS) occurs in 5%–10% of cases of
myocardial infarction (MI) and is accompanied by a 30-day
mortality as high as 60%.1,2 Mechanical circulatory support (MCS) devices have been developed and implemented
for CS, including veno-arterial extracorporeal membrane
oxygenation (VA-ECMO). One disadvantage of peripheral
VA-ECMO is insufficient left ventricular (LV) unloading.
Arterial pressurization increases LV afterload, end-diastolic filling pressure, wall stress and myocardial oxygen
demand.3 One strategy to provide LV unloading is to use
a left atrial cannula to indirectly unload the left ventricle.
Left atrial venous arterial ECMO (LAVA-ECMO) utilizes a
single cannula (VFEM024, Edwards Lifesciences, Irvine,
CA) with a long fenestrated segment (15 cm) decompressing
both the left and right atria. The cannula is inserted using
femoral venous access, necessitating transseptal puncture
and enabling biventricular support while minimizing arterial access (Figure 1).
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Figure 1. Schematic of the transseptal configuration for LAVAECMO. A long cannula that is fenestrated for a length of 30 cm is
inserted across the atrial septum from the right femoral vein. This
cannula draws blood from the left and right atrium simultaneously
takes it through the ECMO circuit to be oxygenated, and then
returns the blood to the femoral artery.
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Figure 2. Process of transseptal access and insertion of the VFEM024 cannula across the atrial septum to provide left and right-sided
unloading for ECMO. (A) Intracardiac echocardiographic (Circle) guided transseptal puncture using a transseptal crossing system (arrow).
A 0.014” Grandslam guidewire (*)provide support for catheter traversal of the interatrial septum. An Impella CP is still supporting the patient.
(B) Balloon dilation of the interatrial septum using an 8 × 40 mm Armada peripheral balloon (dagger)(Abbott Vascular, Santa Clara, CA) to
facilitate cannula traversal. (C) Insertion of a 24Fr VFEM024 (double dagger) (Edwards Lifesciences, Irvine, CA) across the atrial septum. (D)
Transesophageal echocardiography visualizing the transseptal cannula (double arrow) withdrawing blood from both the left and right atrium
simultaneously. AoV, aortic valve; LA, left atrium; RA, right atrium; RV, right ventricle

Discussion
This case illustrates the merits of using LAVA-ECMO in
biventricular dysfunction. Several key steps improved the likelihood of a good outcome including (1) early recognition of
worsening perfusion (2) use of invasive hemodynamics to cater

therapy to a patient-specific phenotype (3) early escalation of
MCS allowing for biventricular support using single arterial
access reducing the risk of vascular access complication.
Ventricular load as demonstrated by an elevated left ventricular end-diastolic pressure is associated with myocardial
ischemia, reduced myocardial salvage and increased risk

Table 1. Hemodynamic Characteristics of LAVA-ECMO from the Time of Cannulation, Device Weaning Trials Until Time
to Transplantation

LAVA-ECMO Flow (L/min)
SvO2 (%)
FICK CI (L/min./m2)
PCWP
PA systolic (mm Hg)
PA diastolic (mm Hg)
PA mean (mm Hg)
CVP (mm Hg)
Hemoglobin (g/dL)
Platelets (K/uL)
BUN (mg/dL)
Creatinine (mg/dL)
Total Bilirubin (mg/dL)

Baseline

Post-LAVA

Day 1

Day 5

Clamp Challenge day 5

Day 6

Day 11

NA
49.5
2.09
30
54
25
38
12
9.2
248
24
1.00
0.5

4
77.2
5.14
22
36
18
26
11
8.2
204
25
1.04
–

4
73.9
4.5
–
33
23
27
11
8.4
188
21
1.09
–

4
64.2
3.3
–
36
19
21
5
7.8
125
36
1.16
–

3.5
74
4.6
–z
74
31
45
10
7.8
125
36
1.00
–

4
62.7
3.1
–
33
18
23
8
7.9
121
36
1.00
–

3.5
61.2
3.3
–
53
25
37
10
7.3
156
26
0.75
0.9

Immediate jump in pulmonary pressures with the LAVA-ECMO circuit clamped and increase in pulmonary artery pressures when the
mechanical support is partially weaned to 3.5 L/min of flow (day 11).
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Table 2. Comparison of Alternative Mechanical Circulatory Support Strategies for Biventricular Failure when Impella
CP is Insufficient
Action

Result

Upgrade to Impella Increase of left-sided cardiac
5.0 or LD (5.5)
output may potentially
address biventricular
failure depending of
degree of right ventricular
dysfunction
Addition of
Unload left and right heart
venous-arterial
ECMO

Access

Advantage

Disadvantage

• Transaxillary
• Simpler to use one device
(surgical cut down) • Direct LV unloading
• Transcaval (Impella • Appropriate temporary bridging
5.0 only)
device
• 2 large-bore
arterial
• 1 large-bore
venous

Upgrade to LAVA- Unload left and right heart
ECMO
Urgent BIVAD
insertion

• 1 large bore
arterial
• 1 large bore
venous
Complete left and right-sided • Open sternotomy
support

Cardiac
Transplantation

Definitive treatment for
biventricular heart failure

• Open sternotomy

of mortality. Strategies to reduce ventricular load have correlated with improved outcomes. Russo et al. performed a
meta-analysis demonstrating the use of LV venting was associated with decreased mortality (OR 0.79 [95%CI 0.72–0.87]
P < 0.00001), but higher rates of hemolysis.4 Al-Fares et al.
performed a meta-analysis demonstrating that LV unloading
improved the ability to wean from MCS (OR 0.62 [0.47–0.83]
P = 0.001); however, survival was similar in both groups.5
Schrage et al. evaluated the use of Impella to provide LV
unloading when using VA-ECMO. The investigators showed
a mortality reduction with LV unloading when compared to
VA-ECMO alone (47% vs. 80%, P < 0.0001). Importantly;
however, the risk of bleeding and access site-related ischemia
were significantly higher in those treated with Impella.6 LAVAECMO is ideally suited in such patients as it uses single arterial
access and provides biventricular support (Table 2).
Strategies to provide LV unloading include left atrial septostomy7 and direct left atrial cannulation.8 Kotani et al. reported
a 6-year experience in which 12.9% of pediatric patients
requiring VA-ECMO underwent left-sided decompression.8
In this cohort, 70% were decannulated and 52% of patients
survived.8 Our configuration differs by using a single cannula
to unload the left and right side of the heart. LAVA-ECMO
is limited by the technical expertise required for transseptal
puncture and possible need for septal closure post-decannulation. Left-to-right shunting would render pulmonary artery
mixed venous readings misleadingly high, complicating management. Furthermore, significant left-to-right shunting could
worsen right ventricular failure and tricuspid regurgitation
while right-to-left shunting may cause hypoxia. It is unclear
if indirect unloading of the ventricle through atrial decompression is more effective than direct ventricular unloading as
seen in axial flow pumps (e.g., Impella). While the data shown
suggests biventricular unloading is occurring, further hemodynamic studies and continuous wave Doppler interrogation of

• Complete biventricular support
• Direct LV unloading
• Appropriate temporary bridging
device
• Technical feasibility reasonable
• Complete biventricular support
• Appropriate temporary bridging
device
• Single large-bore arterial access
• Definitive biventricular support
• Possible to be ambulatory
• Bridging or destination therapy
• Definitive treatment

• Requires an arterial
access >21 Fr
• Hemolysis risk
• Catheter instability risk
• Will not address right
ventricular dysfunction
• Large bore access burden
• Hemolysis risk
• Catheter instability risk
• Indirect LV unloading
• Transseptal access
• Technically more
challenging
• Frequently unavailable
• Inappropriate for acute
decompensation
• Long post-operative
recovery
• Rarely available in acute
decompensation
• Process for
transplantation evaluation
often long

the trans-septal ECMO flow will be needed to confirm unloading. Finally, there are no dedicated devices for unloading the
left and right side of the heart simultaneously and field is in
need of properly designed cannulas.
Conclusions
We report the successful use of LAVA-ECMO as a bridge
to cardiac transplantation. LAVA-ECMO provides biventricular
hemodynamic support using a single arterial access without
the need for additional MCS devices. Consideration for the use
of LAVA-ECMO should occur in tertiary centers with experienced ECMO programs. Further studies are needed to study
the safety and efficacy of such a strategy across a more generalizable population. To our knowledge, this is the first reported
case utilizing LAVA-ECMO as a bridge to transplant.
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